Clinical trial
Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia
NCT00260338 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stem Cell Therapy for Vasculogenesis in Patients With Severe Myocardial Ischemia
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- December 31, 2005
- Completion date
- July 31, 2009
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary heart disease, myocardial ischemia